182 related articles for article (PubMed ID: 37201736)
1. Targeting mitochondrial function in macrophages: A novel treatment strategy for atherosclerotic cardiovascular disease?
Becker PH; Thérond P; Gaignard P
Pharmacol Ther; 2023 Jul; 247():108441. PubMed ID: 37201736
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
[TBL] [Abstract][Full Text] [Related]
4. The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.
Wang Z; Su J; Gong F; Xue L; Su Z
J Cardiovasc Pharmacol; 2022 Sep; 80(3):407-416. PubMed ID: 35853202
[TBL] [Abstract][Full Text] [Related]
5. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.
Zhang X; McDonald JG; Aryal B; Canfrán-Duque A; Goldberg EL; Araldi E; Ding W; Fan Y; Thompson BM; Singh AK; Li Q; Tellides G; Ordovás-Montanes J; García Milian R; Dixit VD; Ikonen E; Suárez Y; Fernández-Hernando C
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782454
[TBL] [Abstract][Full Text] [Related]
6. Macrophage SR-B1 in atherosclerotic cardiovascular disease.
Huby T; Le Goff W
Curr Opin Lipidol; 2022 Jun; 33(3):167-174. PubMed ID: 35258032
[TBL] [Abstract][Full Text] [Related]
7. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
Holvoet P
Verh K Acad Geneeskd Belg; 2008; 70(3):193-219. PubMed ID: 18669160
[TBL] [Abstract][Full Text] [Related]
8. Macrophage death in atherosclerosis: potential role in calcification.
Neels JG; Gollentz C; Chinetti G
Front Immunol; 2023; 14():1215612. PubMed ID: 37469518
[TBL] [Abstract][Full Text] [Related]
9. Macrophage polarization by potential nutraceutical compounds: A strategic approach to counteract inflammation in atherosclerosis.
Sottero B; Testa G; Gamba P; Staurenghi E; Giannelli S; Leonarduzzi G
Free Radic Biol Med; 2022 Mar; 181():251-269. PubMed ID: 35158030
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis.
Salnikova D; Orekhova V; Grechko A; Starodubova A; Bezsonov E; Popkova T; Orekhov A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445694
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
[TBL] [Abstract][Full Text] [Related]
12. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
13. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
Torzewski M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
15. ZBTB20 Positively Regulates Oxidative Stress, Mitochondrial Fission, and Inflammatory Responses of ox-LDL-Induced Macrophages in Atherosclerosis.
Tao J; Qiu J; Lu L; Zhang L; Fu Y; Wang M; Han J; Shi M; Li L; Zhao Z; Wei F; Wang C; Zhang H; Liang S; Zheng J
Oxid Med Cell Longev; 2021; 2021():5590855. PubMed ID: 33777314
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
Ciccarelli G; Conte S; Cimmino G; Maiorano P; Morrione A; Giordano A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674602
[TBL] [Abstract][Full Text] [Related]
17. Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism.
Wei Y; Corbalán-Campos J; Gurung R; Natarelli L; Zhu M; Exner N; Erhard F; Greulich F; Geißler C; Uhlenhaut NH; Zimmer R; Schober A
Circulation; 2018 Oct; 138(18):2007-2020. PubMed ID: 29748186
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria orchestrate macrophage effector functions in atherosclerosis.
Dumont A; Lee M; Barouillet T; Murphy A; Yvan-Charvet L
Mol Aspects Med; 2021 Feb; 77():100922. PubMed ID: 33162108
[TBL] [Abstract][Full Text] [Related]
20. Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.
Chernyavskiy I; Veeranki S; Sen U; Tyagi SC
Ann N Y Acad Sci; 2016 Jan; 1363(1):138-54. PubMed ID: 26849408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
